Teikoku Seiyaku And Taiho Pharmaceuticals Plan Application For Cancer Pain Drug
This article was originally published in PharmAsia News
Executive Summary
Taiho Pharmaceuticals and Teikoku Seikoku announced July 11 they have agreed on a business alliance to work on the cancer pain drug OVF (fentanyl).